mic-4

Ceftolozane sulfate (FR-264205) 是一种头孢菌素类抗生素，具有广谱的抗菌活性，抑制 P. aeruginosa PAO1,抑制假单胞菌，可用于研究肺炎。

PF-04753299 是一种有效的、选择性的LpxC 抑制剂。PF-04753299 对淋球菌分离株具有杀菌作用，对大肠杆菌、铜绿假单胞菌和肺炎菌株的抑制的MIC90值分别为 2 μg ml、4 μg ml 和 16 μg ml。PF-04753299 用于革兰氏阴性菌感染的研究。

4-Chlorosalicylic acid (4-Chloro-2-hydroxybenzoic acid, 4-chloro salicylic acid) 是一种药物中间体。它抑制单酚酶和二苯酚酶活性，IC50值分别为1.89 mM 和1.10 mM。 它有抗菌活性，抑制大肠杆菌的MIC 为250 μg mL，MBC 为500 μg mL。

VP-4604是一种有效的抗耐甲氧西林金黄色葡萄球菌（MRSA）化合物。VP-4604对金黄色葡萄球菌展现出显著的抑制微生物生长的作用，MIC 为4-8μg mL。VP-4604抑制耐甲氧西林金黄色葡萄球菌的生长，其生长抑制率达到95%以上。

2,6-Dichlorodiphenylamine 是双氯芬酸钠的一种结构类似物，显示出抗白色念珠菌活性。2,6-Dichlorodiphenylamine 是非选择性抗炎剂，为COX 的抑制剂，在 CHO 细胞中，对人 COX-1 和 COX-2 的IC50分别为 4 和 1.3 nM。

Octyl gallate (Octyl 3,4,5-trihydroxybenzoate) 具有抗菌、抗氧化作用，有选择性和敏感性的荧光特性，广泛用作食品添加剂。它对 HSV-1，水泡性口炎病毒和脊髓灰质炎病毒有显著的抗病毒作用。

2,4′-Dichloroacetanilide (2-chloro-N-(4-chlorophenyl)acetamide) 具有抗真菌活性，抑制 T. asteroides，其最小抑菌浓度为 6.25 μg mL。

Isoeugenol (4-Propenylguaiacol) 是肉豆蔻，丁香和肉桂的精油成分，具有抗菌活性。它抑制Escherichia coli 和Listeria innocua，MIC 值分别为 0.6 mg mL 和 1 mg mL。

ALPHA-PINENE ((-)-Alpha-Pinene) 是一种双环单萜，存在于松树和其他植物中，包括具有多种生物活性的大麻。它减少了 7 种革兰氏阳性菌、7 种革兰氏阴性菌和 8 种酵母菌株的生长，MIC 值分别为 0.75-1.29、1.05-1.59 和 0.7-1.17%。它对 C. molestus 幼虫具有杀虫活性，LC50 值范围为 47 至 49 mg L。它(100 μg ml) 可诱导细胞凋亡，增加阴离子超氧化物的产生和 DNA 片段化，并激活 B16 中的 caspase-3 F10 黑色素瘤细胞 。在 B16 F10 小鼠异种移植模型中，它（100 ml 的 10 mg ml 溶液）可将转移性肺结节的数量减少约 7 倍。它（8.6 mg L，气溶胶）还使小鼠在高架十字迷宫的张开臂​​中花费的时间增加了大约 2 倍，表明具有抗焦虑活性。

Compound A33 (Antibacterial agent 246) 在治疗23种革兰氏阳性细菌方面表现出色，其最低抑菌浓度范围为0.5 ~ 4 μg mL。此外，当与Polymyxin E联用时，Compound A33 能有效抑制多种革兰氏阴性菌的生长，表现出的部分抑菌浓度指数为0.066。

Altersolanol A（Stemphylin; NSC 173943）在对抗Bacillus subtilis和Pseudomonas aeruginosa方面显示出抗菌活性，其MIC范围为25-100 μg mL。此外，Altersolanol A在4 μg μL剂量下对红豆杉 (Taxus) 没有植物毒性。

OPC-167832 is a potent and orally active dprE1 Inhibitor with an IC50 of 0.258 μM. OPC-167832 has antituberculosis activity and can be used for the research of tuberculosis caused by Mycobacterium tuberculosis[1]. OPC-167832 exhibits very low MICs against laboratory strains of M. tuberculosis H37Rv (MIC: 0.0005 μg ml) and Kurono (MIC: 0.0005 μg ml) and strains with monoresistance to rifampin (RIF), isoniazid (INH), ethambutol (EMB), streptomycin (STR), and pyrazinamide (PZA) (MIC: 0.00024-0.001 μg ml). However, OPC-167832 has minimal or no activity against standard strains of nonmycobacterial aerobic and anaerobic bacteria[1].The IC90 values of OPC-167832 against intracellular M. tuberculosis strains H37Rv and Kurono are 0.0048 and 0.0027 μg ml, respectively. OPC-167832 shows bactericidal activity against intracellular M. tuberculosis at a low concentration, and the bactericidal activity is saturated at concentrations of 0.004 μg ml or higher[1]. OPC-167832 (oral administration; 0.625-10 mg kg) exhibits a good pharmacokinetic characteristic. The plasma reaches peak at 0.5 h to 1.0 h (tmax) and is eliminated with a half-life (t1 2) of 1.3 h to 2.1 h OPC-167832 distribution in the lungs is approximately 2 times higher than that in plasma, and the Cmax and AUCt of OPC-167832 in plasma and the lungs shows dose dependency[1].OPC-167832 (oral administration; 0.625-10 mg kg; 4 weeks) significantly reduces lung CFU compared to the vehicle group. The dose-dependent decrease of lung CFU is observed from 0.625 mg kg to 2.5 mg kg. In a M. tuberculosis Kurono-infected ICR female mice model. OPC-167832 combines with DMD, BDQ, or LVX via oral gavage exhibits significantly higher efficacies than each single agent alone[1].[1].OPC-167832 (oral gavage; 2.5 mg kg; combination with DCMB; 12 weeks) demonstrates the most potent efficacy when compares with DC, DCB. The lung CFU count after 6 weeks of treatment is below the detection limit, and at the end of just 8 weeks of treatment, the bacteria in the lungs of all the evaluated mice had already been eradicate[1]. [1]. Norimitsu Hariguchi, et al. OPC-167832, a Novel Carbostyril Derivative with Potent Antituberculosis Activity as a DprE1 Inhibitor.Antimicrob Agents Chemother. 2020 May 21;64(6):e02020-19.

Chlorhexidine-d8 is intended for use as an internal standard for the quantification of chlorhexidine by GC- or LC-MS. Chlorhexidine is a bis(biguanide) antimicrobial disinfectant and antiseptic agent. It inhibits growth of clinical methicillin-resistant S. aureus (MRSA) isolates (MIC90 = 4 μg ml). It is also active against canine isolates of MRSA, methicillin-susceptible S. aureus (MSSA), methicillin-resistant S. pseudintermedius (MRSP), and methicillin-susceptible S. pseudintermedius (MSSP; MIC90s = 4, 2, 2, and 1 mg L, respectively). Chlorhexidine inhibits growth of E. faecium strains (MICs = 1.2-19.6 μg ml) and C. albicans (MIC = 5.15 μg ml). It generates cations that bind to and destabilize the bacterial cell wall to induce death.6 Chlorhexidine also completely inhibits matrix metalloproteinase-2 (MMP-2) and MMP-9 when used at concentrations of 0.0001 and 0.002%, respectively, in a gelatin degradation assay. Formulations containing chlorhexidine have been used in antisept......

Antibacterial agent 88 是一种有效的抗细菌剂，能够作用于 B. subtilis (MIC: 4 μg ml)，对 MRSA、MRSE 和 S. aureus 的 MIC 值均为 ≤0.0156 μg mL。

Anti-MRSA agent 4 (compound 7a) 为针对耐甲氧西林金黄色葡萄球菌 (MRSA) 的革兰氏阳性菌强效选择性生长抑制剂，具有MIC≤ 0.26 µM的显著效力。此外，该化合物在HEK293细胞中未显示细胞毒性和溶血活性。

1-Methyl-2-[(4Z,7Z)-4,7-tridecadienyl]-4(1H)-quinolone，为喹诺酮类生物碱，作用为二酰基甘油酰基转移酶抑制剂与血管紧张素II受体阻断剂，其IC50值依次为20.1 μM与34.1 μM。此化合物亦展现对幽门螺杆菌的有效抗活性，MIC值达10 μg mL。

Antibacterial agent 101 表现出抗细菌和抗真菌作用(MIC=4-32 μg mL)。

PptT-IN-4 (Compound 3a) 为PptT抑制剂，IC50为0.71 μM。其对MtbH37Rv的MIC值为42 μM，并且还能抑制hERG、hCav1.2和hNav1.5通道，对应IC50s分别为11 μM、8.1 μM、6.9 μM。

ZG297 是一种 Staphylococcus aureus ClpP (SaClpP) 激动剂，EC50 为 0.26 μM。它通过降解 SaFtsZ 来抑制细菌细胞分裂，从而对葡萄球菌（如 S. aureus 8325-4 和 MRSA）的生长表现出抑制作用，MIC 范围为 0.063-256 μg mL。在小鼠模型中，ZG297 展现了显著的抗感染活性。

LolCDE-IN-4 (Compound 1) 显示出对革兰氏阴性细菌Escherichia coli (MIC为 0.25-32 µg ml) 和 Haemophilus influenzae具有抗菌活性，其机制是通过抑制LolCDE复合物以及中断内膜脂蛋白的释放。

3-Hydroxyterphenyllin is a p-terphenyl fungal metabolite originally isolated from A. candidus that has diverse biological activities, including antioxidant, antiproliferative, antibacterial, and antiviral properties.1,2,3,4 It has a 96% scavenging effect on 2,2-diphenyl-1-picrylhydrazyl radicals when used at a concentration of 100 μg/ml.2 3-Hydroxyterphenyllin inhibits the growth of HeLa cervical, A549 lung, and HepG2 liver cancer cells (IC50s = 23, 36, and 32 μM, respectively), as well as methicillin-resistant S. aureus (MRSA) and V. vulnificus bacteria (MIC = 31 μg/ml for both).3 It also inhibits HIV-1 integrase in both coupled and strand transfer assays (IC50s = 2.8 and 12.1 μM, respectively).4References1. Kurobane, I., Vining, L.C., McInnes, A.G., et al. 3-Hydroxyterphenyllin, a new metabolite of Aspergillus candidus. Structure elucidation by 1H and 13C nuclear magnetic resonance spectroscopy. J. Antibiot. (Tokyo) 32(6), 559-564 (1979).2. Yen, G.-C., Chang, Y.-C., Sheu, F., et al. Isolation and characterization of antioxidant compounds from Aspergillus candidus broth filtrate. J. Agric. Food Chem. 49(3), 1426-1431 (2001).3. Wang, W., Liao, Y., Tang, C., et al. Cytotoxic and antibacterial compounds from the coral-derived fungus Aspergillus tritici SP2-8-1. Mar. Drugs 15(11), E348 (2017).4. Singh, S.B., Jayasuriya, H., Dewey, R., et al. Isolation, structure, and HIV-1-integrase inhibitory activity of structurally diverse fungal metabolites. J. Ind. Microbiol. Biotechnol. 30(12), 721-731 (2003). 3-Hydroxyterphenyllin is a p-terphenyl fungal metabolite originally isolated from A. candidus that has diverse biological activities, including antioxidant, antiproliferative, antibacterial, and antiviral properties.1,2,3,4 It has a 96% scavenging effect on 2,2-diphenyl-1-picrylhydrazyl radicals when used at a concentration of 100 μg/ml.2 3-Hydroxyterphenyllin inhibits the growth of HeLa cervical, A549 lung, and HepG2 liver cancer cells (IC50s = 23, 36, and 32 μM, respectively), as well as methicillin-resistant S. aureus (MRSA) and V. vulnificus bacteria (MIC = 31 μg/ml for both).3 It also inhibits HIV-1 integrase in both coupled and strand transfer assays (IC50s = 2.8 and 12.1 μM, respectively).4 References1. Kurobane, I., Vining, L.C., McInnes, A.G., et al. 3-Hydroxyterphenyllin, a new metabolite of Aspergillus candidus. Structure elucidation by 1H and 13C nuclear magnetic resonance spectroscopy. J. Antibiot. (Tokyo) 32(6), 559-564 (1979).2. Yen, G.-C., Chang, Y.-C., Sheu, F., et al. Isolation and characterization of antioxidant compounds from Aspergillus candidus broth filtrate. J. Agric. Food Chem. 49(3), 1426-1431 (2001).3. Wang, W., Liao, Y., Tang, C., et al. Cytotoxic and antibacterial compounds from the coral-derived fungus Aspergillus tritici SP2-8-1. Mar. Drugs 15(11), E348 (2017).4. Singh, S.B., Jayasuriya, H., Dewey, R., et al. Isolation, structure, and HIV-1-integrase inhibitory activity of structurally diverse fungal metabolites. J. Ind. Microbiol. Biotechnol. 30(12), 721-731 (2003).

Piliformic acid is a fungal metabolite that has been found inN. pseudotrichiaand has diverse biological activities.1,2It is cytotoxic to BC-1 human breast cancer cells (IC50= 5 μg ml).2Piloformic acid is active againstL. braziliensisamastigotes (IC50= 78.5 μM). It is also active against the plant pathogenic fungiC. gloeosporioides(MIC = 292 μM).1 1.Elias, L.M., Fortkamp, D., Sartori, S.B., et al.The potential of compounds isolated from Xylaria spp. as antifungal agents against anthracnoseBraz. J. Microbiol.49(4)840-847(2018) 2.Cota, B.B., Tunes, L.G., Maia, D.N.B., et al.Leishmanicidal compounds of Nectria pseudotrichia, an endophytic fungus isolated from the plant Caesalpinia echinata (Brazilwood)Mem. Inst. Oswaldo Cruz113(2)102-110(2018)

Lytixar is a Synthetic Antimicrobial Peptide, it shows activity against Daptomycin-Nonsusceptible, Methicillin-Resistant, Vancomycin-Intermediate, Vancomycin-Resistant, and Linezolid-Nonsusceptible Staphylococcus aureus. LTX-109 demonstrated a MIC range o

LpxC-IN-5 is a potent, non-hydroxamate inhibitor of LpxC, which is an enzyme known as UDP-3-O-acyl-N-acetylglucosamine deacetylase. It exhibits an IC50 value of 20 nM. Furthermore, LpxC-IN-5 displays antibacterial activity against various strains including E. coli ATCC25922, P. aeruginosa ATCC27853, K. pneumoniae ATCC13883, and P. aeruginosa 5567. The minimum inhibitory concentration (MIC) values for these strains are 16 μg/mL, 4 μg/mL, 64 μg/mL, and 4 μg/mL, respectively.